ProPhase Labs, Inc. (PRPH) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $11.96M2009: $12.80M2010: $8.23M2011: $5.54M2012: $572.0K2013: $1.64M2014: $2.93M2015: $1.66M2016: $441.0K2017: $3.17M2018: $1.55M2019: $434.0K2020: $6.82M2021: $8.41M2022: $9.11M2023: $1.61M2024: $678.0K2025: $90.0K$90.0K
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$90.0K-86.7%
2024$678.0K-57.9%
2023$1.61M-82.3%
2022$9.11M+8.3%
2021$8.41M+23.4%
2020$6.82M+1470.5%
2019$434.0K-72.1%
2018$1.55M-51.0%
2017$3.17M+619.5%
2016$441.0K-73.5%
2015$1.66M-43.1%
2014$2.93M+78.6%
2013$1.64M+186.4%
2012$572.0K-89.7%
2011$5.54M-32.7%
2010$8.23M-35.7%
2009$12.80M+7.1%
2008$11.96M